Loading…
Akums Drugs and Pharmaceuticals (AKUMS)₹765.85+2.96%Pharmaceuticals
Akums Drugs and Pharmaceuticals is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 41.2 against a peer median of 41.2, and ROCE of 15.0% against a peer median of 17.1%, and latest-quarter sales growth of 14.0% against a peer median of 17.3%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CORONA Remedies | 15,541 | 74.9 | 33.0 | 29.5 | 0.22 | 0.4 | 1,403 | 185 | 22.3 | 15.3 | vs AKUMS |
| Jubilant Pharmova | 15,359 | 43.7 | 8.9 | 6.6 | 0.51 | 0.5 | 8,307 | 398 | 17.3 | −45.1 | vs AKUMS |
| Natco Pharma | 14,403 | 12.6 | 17.1 | 16.9 | 0.08 | 0.6 | 4,089 | 1,414 | −44.7 | −57.1 | vs AKUMS |
| Marksans Pharma | 13,979 | 27.0 | 19.0 | 15.2 | 0.11 | 0.3 | 2,954 | 421 | 35.7 | 174.2 | vs AKUMS |
| Sudeep Pharma | 13,676 | 72.4 | 27.9 | 25.2 | 0.17 | 0.1 | 641 | 174 | 20.7 | 10.6 | vs AKUMS |
| Concord Biotech | 12,533 | 44.3 | 17.0 | 12.5 | 0.00 | 0.6 | 1,052 | 258 | 25.2 | 11.0 | vs AKUMS |
| Akums Drugs and Pharmaceuticals | 12,024 | 41.2 | 15.0 | 8.5 | 0.05 | 0.1 | 4,347 | 255 | 14.0 | 55.5 | — |
| Viyash Scientific | 10,379 | 41.0 | 13.0 | 7.4 | 0.17 | 0.0 | 3,432 | 225 | 19.3 | 113.3 | vs AKUMS |
| Blue Jet Healthcare | 10,273 | 40.2 | 26.0 | 19.9 | 0.03 | 0.2 | 946 | 248 | −17.4 | −14.3 | vs AKUMS |
| Symbiotec Pharmalab | 9,997 | 88.5 | 13.0 | 11.7 | 0.34 | 0.0 | 867 | 110 | 7.5 | −53.3 | vs AKUMS |
| Procter & Gamble Health | 9,461 | 26.6 | 83.9 | 61.7 | 0.02 | 2.7 | 1,404 | 326 | 7.4 | 45.3 | vs AKUMS |
| Peer median | 12,533 | 41.2 | 17.1 | 15.2 | 0.11 | 0.3 | 1,404 | 255 | 17.3 | 11.0 |
Listed companies closest to Akums Drugs and Pharmaceuticals in Pharmaceuticals include CORONA Remedies, Jubilant Pharmova, Natco Pharma, Marksans Pharma, Sudeep Pharma, Concord Biotech, Viyash Scientific, Blue Jet Healthcare.
CORONA Remedies, with a market cap of ₹15,541 Cr.
Akums Drugs and Pharmaceuticals trades at a P/E of 41.2; the median of its peer set is 41.2. A P/E above or below the median is a description, not a judgement on value.
Akums Drugs and Pharmaceuticals' return on capital employed is 15.0%, below the peer median of 17.1%.